St. John's Wort Oil for Wound Healing and Pain After Cesarean Section
The Effect of St. John's Wort Oil on Wound Healing and Pain in Women Undergoing Cesarean Section: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Cesarean section refers to the surgical procedure in which the fetus is delivered via an incision, typically performed when vaginal delivery is not possible due to high-risk conditions. In recent years, the rate of cesarean deliveries has increased significantly. The quality of treatment and care is crucial in ensuring proper surgical wound healing following cesarean birth. Various new methods and products have been developed for wound healing and care in recent years, some of which are derived from herbal sources. The limitations of pharmacological methods used in the postpartum period, such as treatment failure, concerns about potential harm to the mother and infant, adverse side effects, negative impact on breastfeeding, emergence of resistant microorganisms, and ineffectiveness of current antibiotics, have led individuals to seek alternative natural remedies. Hypericum perforatum (commonly known as St. John's Wort) is frequently used in the postpartum period due to its antimicrobial and antioxidant properties. This study aims to examine the effects of Hypericum perforatum on wound healing and pain in women following cesarean delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
June 10, 2025
CompletedStudy Start
First participant enrolled
June 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedJune 10, 2025
May 1, 2025
6 months
May 30, 2025
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
pre-test post-test
In the first follow-up, a dressing will be made with St. John's wort oil and the woman will be told how to make a dressing with this oil. It will be explained to the woman to make a dressing with St. John's wort oil at the incision site once a day every day. The incision site will be photographed for women who give permission.
6 months
pre-test post-test
On the 15th day, which is the second follow-up, the wound site will be evaluated by the researcher. The incision site of the women who give permission will be photographed. She will be told to continue the application of St. John's wort oil.
6 months
pre-test post-test
The third follow-up will be performed on the 25th postpartum day. REEDA Scale and NRS Scale will be applied. REEDA Scale: REEDA scale is used in the evaluation of episiotomy and cesarean incision wounds. The REEDA scale was developed by Davidson in 1970 and used in his master's thesis on the monitoring of wound healing in the perineum. The validity and reliability study of the scale was conducted by Hill in 1990. In Turkey, the validity and reliability study of the REEDA Scale was conducted by Üstünsöz and used in her master's thesis titled "The Effect of Hot and Cold Applications in Episiotomy Healing". The scale has five sub-dimensions: redness, edema, ecchymosis, discharge and approximation of wound edges. Each sub-dimension of the scale is graded using a 4 (four) point Likert-type rating. The evaluation is made between 0-3. The sum of the scale score varies between 0-15. The higher the scale score, the worse the wound healing.
6 months
Study Arms (2)
Experimental group
EXPERIMENTALAt the first follow-up, wound dressing will be performed using St. John's Wort oil, and participants will be instructed on how to apply the dressing themselves. They will be advised to apply the oil to the incision site once daily. With the participant's consent, photographs of the incision area will be taken. At the second follow-up, on postpartum day 15, the incision site will be evaluated by the researcher. With consent, photographs of the incision site will again be taken. Participants will be instructed to continue applying the oil daily. The third follow-up will take place on postpartum day 25, during which the REEDA Scale and the Numeric Rating Scale (NRS) will be administered to assess wound healing and pain.
control
NO INTERVENTIONNo intervention will be made to the control group. Only measurements will be made on parallel dates with the experimental group.
Interventions
Dressing the incision site with St. John's wort oil once a day every day
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the research,
- Having had a cesarean section,
- Her first cesarean section,
- Being fluent in Turkish.
You may not qualify if:
- Not wanting to participate in the research,
- The existence of a communication barrier.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sakarya Üniversity
Sakarya, 54000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Bilge Nur Yıldırım Bayraktar, PhD
sakarya üniversity
- STUDY DIRECTOR
Kevser İLÇİOĞLU Associate Professor, PhD
sakarya üniversity
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Dr.
Study Record Dates
First Submitted
May 30, 2025
First Posted
June 10, 2025
Study Start
June 25, 2025
Primary Completion
December 30, 2025
Study Completion
April 30, 2026
Last Updated
June 10, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share